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When the phorbol ester, 4/J-phorbol- lZmyristate-13-acetate (PMA) or bacterial phospholipase C (PL-C) 
is added to a preparation of purilied adult rat Leydig cells, containing 2 mM CaCl,, a time- and dose-depen- 
dent decrease of LH-stimulated testosterone production is observed. After a 3 h stimulation with oLH (100 
ng/ml), PMA (100 ng/ml) and PL-C (1.6 U/ml) do not affect the cell viability or the hCG specific binding, 
while CAMP accumulation is significantly reduced; CAMP-stimulated steroidogenesis diminished only in 
the presence of PL-C. These observations uggest hat in vitro: (i) activated Ca*+- and phospholipid-depen- 
dent protein kinase is implicated in the regulation of rat Leydig cell steroidogenesis by LH at a step before 
the adenylate cyclase; (ii) phospholipids play an important role in CAMP-stimulated testosterone synthesis. 
Leydig cell Steroidogenesis 
1. INTRODUCTION 
Recent studies (review [ 11) have demonstrated 
that phosphatidylinositol turnover may regulate a 
novel protein kinase, the protein kinase C (PK-C) 
which is present in all organs including testes [2,3] 
but usually inactive. In vivo, this enzyme is ac- 
tivated by diacylglycerol in the presence of both 
Ca2+ and phospholipids [l]. It is also possible to 
activate PK-C using phospholipase C (PL-C); this 
enzyme hydrolyses all the phosphatidylinositol 
content within seconds and produces diacylgly- 
cerol which in turn activates PK-C. Direct activa- 
tion of PK-C is obtained using a tumor-promoting 
phorbol ester (i.e. PMA) which is able to substitute 
for diacylglycerol; moreover, PK-C may regulate 
cell functions via protein phosphorylation [l]. In 
adrenocortical cells, it has been shown that angio- 
tensin and acetylcholine regulate steroidogenesis 
via PK-C [4,5] and that PK-C phosphorylates in 
Parts of this work were presented as abstract at the 12th 
annual meeting of the Greek Endocrine Society, Athens, 
December 8-9, 1984 
* To whom correspondence should be addressed 
Phorbol ester Phospholipase C 
vitro the cytochrome P-450 involved in cholesterol 
side chain cleavage [6]. Steroidogenesis of rat 
Leydig cells is stimulated by LH through activation 
of a CAMP dependent protein kinase in which 
phospholipids seem to be implicated [7]. In mouse 
Leydig cells, phorbol esters inhibit hCG-stimulated 
testosterone production only if submaximal doses 
of hCG are used [8]. Here, we have investigated 
the implication of phosphatidylinositol turnover 
and PK-C in steroidogenesis of purified rat Leydig 
cells. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Powdered Ham F12 and DME media were pur- 
chased from Seromed. Collagenase-dispase and 
PL-C from Bacillus cereus (spec. act. 800 U/mg 
protein) were from Boehringer. Soybean trypsin 
inhibitor (STI), deoxyribonuclease I, q- 
phorbol-12-myristate-13-acetate (PMA), human 
transferrin and bovine insulin were from Sigma. 
Iodogen was purchased from Pierce. Ovine lu- 
teinizing hormone (NIH-oLH-24) was from 
NIADDK, highly purified hCG (CR-121, 
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13450 IU/mg) was a gift from Dr Canfield (New 
York). Unlabelled hCG (Pregnyl) was from 
Organon, testosterone antibody from Biomerieux; 
cyclic AMP kit used for radioimmunoassay (RIA) 
and iodine were from Amersham. 
2.2. Purification and incubation of rat Leydig 
cells 
Adult Sprague-Dawley rats (70-80 days old) 
were killed by decapitation; the testes were quickly 
removed and decapsulated. The crude interstitial 
cells were prepared following collagenase-dispase 
(O.OSVo) treatment in the presence of ST1 (0.005%) 
and deoxyribonuclease I (0.001 (r/o). Purified 
Leydig cells were obtained after centrifugation on 
a discontinuous Percoll gradient [9] but without 
fetal calf serum. The percentage of Leydig cells ob- 
tained (280%) was determined by histochemical 
staining for 3&hydroxysteroid dehydrogenase 
[lo]; the cell viability was around 90% as deter- 
mined by the NADH-dependent diaphorase activi- 
ty [Ill. 
All cell preparations and incubations were per- 
formed in Ham F12/DME medium (1: 1, v/v) con- 
taining 2 mM CaClz, buffered with 15 mM Hepes 
and 13 mM sodium bicarbonate to which were 
added penicillin (50 U/ml) and streptomycin 
(50 pg/ml). Leydig cells (10’) were incubated 3 h at 
32°C under OJCO2 (95:5, v/v) in 400~1 of 
medium supplemented with insulin (10 pg/ml), 
transferrin (5 pg/ml) and different substrates to be 
studied. Testosterone and CAMP [12] were 
measured by RIA in the cell culture media. The 
inter- and intra-assay coefficients of variation were 
5% and the sensitivity 4 pg/tube for testosterone 
determinations. The inter- and intra-assay coeffi- 
cients of variation of CAMP measurements were 5 
and 9.4%, respectively, and the sensitivity 
0.1 pmol/tube. 
2.3. 12’I-hCG binding studies 
Highly purified hCG was iodinated using 
iodogen and the specific activities obtained ranged 
between 35 and 45 &i/pg. The binding of i2’I- 
hCG in the presence of an excess of rat testis mem- 
branes ranged between 30 and 40%. Leydig cells 
(0.25 x 106) were incubated with or without PL-C 
(1.6 U/ml) or PMA (100 ng/ml) in presence of 
labelled hCG (2 ng). Non-specific binding was 
determined in parallel incubations to which an ex- 
cess of unlabelled hCG was added (100 IU 
Pregnyl). All incubations were performed at 32°C 
for 3 h, then the cells were washed twice with 2 ml 
ice-cold phosphate-buffered saline containing 
0.1% BSA and centrifuged (2500 x g, 15 min, 
4°C). The washed pellet was dissolved in 1 ml of 
0.5 N sodium hydroxide and the radioactivity 
counted. 
2.4. Statistical analysis 
The data obtained were analyzed using the Stu- 
dent’s t-test. 
3. RESULTS 
A saturating concentration of LH (100 ng/ml) 
caused a lo-fold stimulation of purified rat Leydig 
cell testosterone synthesis after 3 h incubation 
(10.16 + 0.4 ng vs 1 f 0.2 ng, basal production per 
lo5 cells). The LH stimulatory effect was inhibited 
by PL-C and PMA in a dose-dependent manner 
(fig.1); the EDso values were 0.75 U/ml for PL-C 
and 44 ng/ml for PMA. Using very low concentra- 
tions of PL-C (0.08 U/ml) and PMA (1 ng/ml), a 
significant decrease of LH-stimulated testosterone 
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Fig.1. Testosterone production in purified rat Leydig 
cells incubated in the presence of oLH (100 ng/ml) and 
increasing concentrations of PL-C (o---e) or PMA 
(M). Results are means + SE of 3 separate 
experiments performed in duplicate; ** p < 0.01, 
*** p < 0.001. Log scale on abscissa. 
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synthesis was observed (22 and 25’7’0, respectively, 
with PL-C and PMA). 
For further studies, we chose doses of 1.6 U/ml 
PL-C and 100 ng/ml PMA which caused 60% in- 
hibition. Basal testosterone production (fig.2) and 
CAMP extracellular accumulation (table 1) were 
unaffected by either PL-C or PMA. Cell viability 
also remained stable (about 9OYo) as well as the 
specific binding of 1251-hCG to LH/hCG mem- 
brane receptors (table 2). However, under LH 
stimulation, the CAMP levels were significantly 
decreased (p < 0.001) by PL-C and PMA (table 1). 
Fig.2. Time-related effects on the secretory pattern of 
testosterone in Leydig cells alone (M) or incubated 
either with PL-C (1.6 U/ml), PMA (100 ng/ml) 
(o---+) or with oLH (100 ng/ml) (o--O), oLH -k PL- 
C(r *** A), oLH + PMA (A---A). Values are means k 
SE (n = 3). Log scale on abscissa. 
Table 1 
Effect of PL-C and PMA on CAMP extracellular 
accumulation 
Treatment CAMP (pmol/105 cells 
per 3 h) 
_ 6.29 k 0.75 (8) 
PL-C (1.6 U/ml) 6.79 + 0.87 (8) 
PMA (100 ng/ml) 5.79 + 0.84 (7) 
LH (100 ng/ml) 29.28 + 1.31 (8) 
LH + PL-C 15.91 + 0.44 (7) 
LH + PMA 20 t 0.69 (4) 
Values are means -t SE (number of experiments in 
parentheses) 
The inhibitory action of PL-C and PMA on LH- 
regulated Leydig cell testosterone production is a 
time-dependent process (fig.2): a first period of 
complete inhibition of LH-stimulated testosterone 
synthesis is observed, the length of this period be- 
ing 20 min when cells are incubated with PMA and 
40 min with PL-C; after this time, steroidogenesis 
started increasing under LH. When dbcAMP 
(1 mM) was added to Leydig cell medium, a 9-fold 
increase of testosterone synthesis was observed 
(8.82 k 0.5 ng) (fig.3); the addition of PL-C 
reduces this process (56%) while PMA is ineffec- 
tive (fig.3). 
Table 2 
Effects of PL-C and PMA on “‘1-hCG specific binding 
on purified Leydig cells 
Treatment ““I-hCG, 
specific binding 
_ 100 f 8.6 
PL-C (1.6 U/ml) 103 t- 8.8 
PMA (100 ng/ml) 96 f 8.7 
Values are expressed as percentage of control (n = 3) 
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Fig.3. Effects of PL-C (1.6 U/ml) and PMA 
(100 ng/ml) on dbcAMP (1 mM) stimulated 
testosterone synthesis in Leydig cells. Values are 
means + SE; *** p < 0.001. 
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4. DISCUSSION 
Two different approaches have been used to 
study the role of PK-C in the regulation of 
steroidogenesis in purified rat Leydig cells: (i) 
directly with PMA, a potent activator of PK-C, 
and (ii) indirectly using PL-C which increases the 
intracellular pool of diacylglycerol and so activates 
PK-C [l]. Leydig cells are incubated in medium 
containing 2 mM CaClz which promotes a max- 
imal activation of PK-C [l]. PL-C and PMA do 
not affect Leydig cell viability or ‘251-hCG binding 
as well as basal CAMP and testosterone produc- 
tion. These observations demonstrate that any 
non-specific effects of PL-C or PMA on Leydig 
cell membranes can be excluded and that activa- 
tion of PK-C, in the absence of physiological 
stimuli, does not alter Leydig cell function. Under 
a saturating concentration of LH, which stimulates 
maximally CAMP and testosterone syntheses, PL- 
C and PMA inhibit this process in a dose- and 
time-dependent manner. These results are different 
from those of Mukhopadhyay et al. [8] who found 
that PMA has no effect on testosterone synthesis 
in mouse Leydig cell suspensions in the presence of 
a saturating concentration of LH; but, when sub- 
maximal doses of LH are used, PMA inhibits 
testosterone synthesis. Similar results to ours have 
been observed with purified bovine luteal cells (P. 
Leymarie, personal communication). The above 
results and the absence of any effect of PMA, but 
not of PL-C, on dbcAMP-stimulated testosterone 
synthesis show that PMA inhibits LH-regulated 
steroidogenesis at a step before adenylate cyclase 
which is in ‘agreement with the results of 
Mukhopadhyay~ et al. [8], while PL-C seems to 
have two sites of action: the first before adenylate 
cyclase and the second beyond. As we found no ef- 
fect of PL-C or PMA on ‘*‘I-hCG specific binding 
to LH-hCG receptors, we suppose that activation 
of PK-C by PL-C or PMA leads to phosphoryla- 
tion of membrane substrates which in turn alter the 
transmission of the hormonal signal or the 
adenylate cyclase activity and so, inhibit the 
stimulation of Leydig cell steroidogenesis by LH. 
This hypothesis is further supported by the time- 
related pattern of action of PL-C and PMA on 
LH-stimulated testosterone production where 2 
distinct periods can be observed: (i) a first short 
period in which LH action is probably inhibited by 
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the phosphorylated substrate of PK-C or by altera- 
tion of the membrane structures; (ii) a second 
period during which the Leydig cells become 
responsive to LH. Our findings do not permit one 
to suppose an action of PK-C on the cholesterol 
side chain cleavage as shown by Vilgrain et al. [6] 
on adrenocortical cells in vitro. The inhibitory ac- 
tion of PL-C on dbcAMP-stimulated testosterone 
production is in agreement with the findings of 
Lowitt et al. [7] showing that phospholipids are in- 
volved in the CAMP-dependent stimulation of 
steroidogenesis. 
In conclusion, the above data demonstrate that 
the activated Ca*+- and phospholipid-dependent 
protein kinase exerts a negative control on LH- 
stimulated steroidogenesis in purified rat Leydig 
cells in vitro. These results are in agreement with 
those of Culty et al. [4] showing that PMA inhibits 
ACTH-induced steroidogenesis in adrenocortical 
cells. 
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